Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative

3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now

AstraZeneca upgraded to Neutral from Sell at UBS

AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg

AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US

Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time

AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades

FTSE 100 and European-listed stocks to own in 2025, according to Barclays

CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC

AstraZeneca’s Tagrisso recommended for approval in EU by CHMP for certain NSCLC

CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC